Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05733819

Responders to Rhythmic Auditory Cueing in Parkinson Disease

Conditions: Parkinson Disease

Sex: All
Ages: 18 Years – 80 Years
Phase: PHASE1
Enrollment: 30
Sponsor: Boston University Charles River Campus

Location: United States

Summary

Parkinson disease (PD) is the second most common neurodegenerative disease affecting approximately 10 million people worldwide. It is a complex movement disorder that results in reduced walking ability. Prior studies have identified declines in walking as a marker of ensuing disability. Rhythmic auditory stimulation (RAS) is a rehabilitation approach that employs the coupling of auditory cues with movement. Walking with RAS has been shown to benefit walking rhythmicity, quality, and speed. These walking benefits make RAS advantageous in promoting regular moderate-intensity walking activity -- an important health objective in the management of PD. However, there is limited research investigating the effects of RAS on walking quality and how improvements in walking speed are achieved. This study will enroll 30 individuals with mild to moderate PD where each participant will be asked to complete two six-minute walk tests, one standard test (baseline) and the other using an optimized metronome-based auditory cueing RAS intervention. The investigators hypothesize that individuals with PD will either walk farther or with more automaticity (i.e., reduced stride time variability) in the RAS condition compared to the baseline condition. Moreover, these walking improvements will be accompanied by improvements in gait mechanics and metabolic cost of walking.

Eligibility Criteria

Inclusion Criteria:Be able to communicate with investigators clearlyDiagnosis of Parkinson's disease (self-report)The ability to walk continuously without another individual supporting the person's body weight for at least 6 minutes. Assistive devices, such as a cane, are allowed.Exclusion Criteria:Inability to communicate (as assessed by a licensed physical therapist)Parkinson's disease, score < 23 on the MMSE.Pain that impairs walking ability (as assessed by a licensed physical therapist)Unexplained dizziness in the last 6 months (self-report)Severe comorbidities that may interfere with the ability to participate (musculoskeletal, cardiovascular, pulmonary, and neurological)More than 2 falls in the previous month

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05733819). StuddyBuddy aggregates publicly available trial information.